-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades uniQure BV (QURE) to Neutral following FDA recommendation
-
-
-
-
-
-
-
Options with increasing option implied volatility: MSTU XXRP ETHU QURE MSTZ BITX
-
-
-
-
-
-
-
uniQure BV (QURE) PT Lowered to $33 at Mizuho
-
-
-
-
-
-
-
uniQure BV (QURE) PT Lowered at RBC Capital After a 'Disappointing Regulatory Update'
-
-
-
-
-
-
-
UniQure faces FDA setback on Huntington's disease gene therapy
-
-
-
-
-
-
-
uniQure BV (QURE) PT Raised to $65 at Wells Fargo
-
-
-
-
-
-
-
uniQure (QURE) to Resume Trading at 7:35 a.m.
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

